This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI DISHEVELLED 2
catalog :
VMA00375
quantity :
100 µl
price :
346 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
OTI7C7
reactivity :
human
application :
western blot
product information
EntityType :
PrecisionAb Monoclonal
EntityCategory :
Antibodies
ProductCode :
VMA00375
Description :
MOUSE ANTI DISHEVELLED 2
Specificity :
DISHEVELLED 2
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB
ApplicationTypes :
Western Blotting
Clone :
OTI7C7
Quantity :
100 µl
QuantityValue :
100
QuantityType :
ul
GOAccessions :
GO:0021987,GO:0043507,GO:0044340,GO:0045893,GO:0051091,GO:0060071,GO:0001843,GO:0001934,GO:0004871,GO:0005109,GO:0005634,GO:0005737,GO:0006366,GO:0007379,GO:0007507,GO:0042802,GO:0021766
GOTerms :
activation of protein amino acid phosphorylation,positive regulation of protein amino acid phosphorylation,stimulation of protein amino acid phosphorylation,up regulation of protein amino acid phosphorylation,upregulation of protein amino acid phosphorylation,up-regulation of protein amino acid phosphorylation,GO:0005062,GO:0009369,GO:0009370,gp130,hematopoietin/interferon-class (D200-domain) cytokine receptor signal transducer activity,quorum sensing response regulator activity,quorum sensing signal generator activity,frizzled ligand,fz binding,fz ligand,cell nucleus,transcription from Pol II promoter,cardiac development,dorsal vessel development,GO:0007511,isoform-specific homophilic binding,protein homopolymerization,neocortex development,positive regulation of JUNK activity,stimulation of JNK activity,up regulation of JNK activity,upregulation of JNK activity,up-regulation of JNK activity,canonical Wnt receptor signalling pathway involved in regulation of cell proliferation,activation of transcription, DNA-dependent,positive regulation of cellular transcription, DNA-dependent,stimulation of transcription, DNA-dependent,up regulation of transcription, DNA-dependent,up-regulation of transcription, DNA-dependent,upregulation of transcription, DNA-dependent,activation of transcription factor activity,stimulation of transcription factor activity,up regulation of transcription factor activity,upregulation of transcription factor activity,up-regulation of transcription factor activity,non-canonical Wnt signaling pathway,PCP pathway,Wnt receptor signalling pathway, planar cell polarity pathway,Wnt-JNK signaling pathway,Wnt-PCP signaling pathway
UniprotAccessions :
O14641
Gene :
DVL2
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1856
EntityFormats :
Purified
UNSPSC :
41116161
ProductForm :
Purified IgG - liquid
PriceGBP :
262
PriceEUR :
336
PriceUSD :
346 USD
PriceCHF :
366.24
PriceSEK :
3531
PriceNOK :
3599
PriceDKK :
2507
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.